Head-to-head · Cost-Efficiency Index
Allara Health vs OurView Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Allara Health
Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Visit Allara HealthOurView Health
Cost-first shoppers who want low-cost compounded GLP-1 via a membership savings model.
Visit OurView HealthThe verdict
Allara Health and OurView Health tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with Allara Health (ranked #204, a hair above #210) — Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself. But OurView Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Allara Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Allara Health | OurView Health |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $149/mo (plus a separate fee, brand-name) | $75/mo (starting dose, compounded) |
| Tirzepatide / mo | Not disclosed | $135/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $900 |
| Tirzepatide / yr (modeled) | — | $1,620 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #204 | #210 |
Allara Health
62/100Where the value is
- In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
- Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform
The tradeoffs
- No GLP-1 medication price is published anywhere on the site — the $149/mo figure is a visit/membership fee only, and actual drug cost depends entirely on insurance or is undisclosed for self-pay
- Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
OurView Health
62/100Where the value is
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
The tradeoffs
- A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
- Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.